
The acquisition brings Gallant’s experimental stem cell treatments for feline chronic gingivostomatitis and osteoarthritis in dogs and cats into Dechra’s portfolio.
Dr. Christine Merle, MBA, CVPM with Brakke Consulting in Dallas, explains why the purpose of your business is to make money.

